Additional file 6 of VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody

Abstract

Additional file 6: Figure S5. VEGF-A is increased in the spinal cord of mice with oxaliplatin-induced neuropathy. Representative western blot images and densitometric analysis of VEGF-A expression in the lumbar section of the spinal cord of oxaliplatin-treated mice in comparison to control (n=4). Each value represents the mean ± SEM. *P<0.05 vs vehicle group. The analysis of variance was performed by one-way ANOVA. A Bonferroni’s significant difference procedure was used as post-hoc comparison